Indefinite Delivery Contract 75Q80125D00005

Award Date 7/1/25
Last Date to Order 6/30/30
Federal Agency
AHRQ Headquarters
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) with the Agency for Healthcare Research and Quality (AHRQ) is for Evidence-Based Practice Center (EPC) services to provide a variety of evidence synthesis products. The contract holder will respond to task orders from AHRQ and other federal partners to produce reports such as systematic reviews, scoping reviews, living reviews, rapid reviews, and qualitative evidence synthesis across medical specialties. The contract is a multiple award IDIQ with a $90...
This Indefinite Delivery Contract (IDC) award by the Agency for Healthcare Research and Quality (AHRQ) to Kaiser Foundation Hospitals aims to procure evidence synthesis services for AHRQ's Evidence-based Practice Center (EPC) program. The $90 million, multiple-award IDC has a period of performance from November 2024 to November 2029. The contract requires the prime contractor to provide a range of evidence synthesis products including systematic reviews, scoping reviews, living reviews, rapid...
The federal contract IDV award is for the Agency for Healthcare Research and Quality's (AHRQ) Evidence-based Practice Center (EPC) VII program. The $90 million, multiple-award IDIQ contract has a period of performance from July 2025 to June 2030. The prime contractor, Emergency Care Research Institute (Ecri), is a non-profit organization that provides healthcare quality and safety services to federal agencies. Under this IDV, Ecri will deliver a variety of evidence synthesis products,...
The federal contract IDV award is for the Evidence-based Practice Center (EPC) VII program, which is administered by the Agency for Healthcare Research and Quality (AHRQ), a civilian federal agency. The prime contractor is The RAND Corporation, a non-profit global policy think tank. The contract aims to procure evidence synthesis services, including systematic reviews, scoping reviews, living reviews, rapid reviews, and qualitative evidence synthesis across a wide range of medical specialties....
The federal contract IDV award is for the Agency for Healthcare Research and Quality's (AHRQ) Evidence-based Practice Center (EPC) program. The $90 million, multiple-award IDIQ contract runs from July 2025 to June 2030, with the prime contractor being the Mayo Clinic. The contract aims to procure a range of evidence synthesis services, including systematic reviews, scoping reviews, living reviews, rapid reviews, and qualitative evidence synthesis across various medical specialties. These...
This indefinite delivery contract (IDC) was awarded by the Agency for Healthcare Research and Quality (AHRQ) to the University of Southern California (USC) to provide evidence synthesis services for the AHRQ Evidence-based Practice Center (EPC) program. The multiple-award IDC has a $90 million ceiling value and a period of performance from July 1, 2025 to June 30, 2030. Under this contract, USC will produce various types of evidence reports, including systematic reviews, scoping reviews,...
The Agency for Healthcare Research and Quality (AHRQ), a civilian agency within the U.S. Department of Health and Human Services, awarded an indefinite-delivery, indefinite-quantity (IDIQ) master contract to Oregon Health & Science University (OHSU) called the Evidence-based Practice Centers VI (EPC VI) contract. The contract has a ceiling value of $0.00, allowing AHRQ to issue task orders to OHSU as needed. The EPC VI contract is for OHSU, a prominent research university and academic...
This Indefinite Delivery Contract (IDC) was awarded by the Agency for Healthcare Research and Quality (AHRQ), a civilian federal agency, to Brown University, a private Ivy League university, to provide evidence synthesis services for the Evidence-based Practice Center (EPC) program. The IDC has a ceiling value of $90,000 and a period of performance from July 1, 2025 to June 30, 2030. Under this multiple award contract, Brown University will respond to task orders to produce various types of...
This federal contract IDV award, valued at up to $350,000,000, was issued by the Health Resources and Services Administration (HRSA) to provide a contract mechanism for evidence building and evaluation services. The single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract has a period of performance of one base year with four one-year options, and is not set aside for any specific business type. The contract covers four key task areas: 1) Program Evaluations, 2) Other Evidence...
The Department of Health and Human Services (HHS) awarded an Indefinite Delivery Contract (IDC) to the Emergency Care Research Institute (ECRI), a nonprofit organization, to provide OTHER PROFESSIONAL SERVICES. The single-award IDC has an unlimited ceiling value and a period of performance through August 30, 2017. ECRI has been contracted to deliver a wide range of specialized healthcare-related services to various federal agencies, including the Department of Veterans Affairs, Agency for...

This is a multiple award Indefinite Delivery Contract (IDC) awarded by the Agency for Healthcare Research and Quality (AHRQ) to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) for the Evidence-based Practice Center (EPC) VII program. The contract has a ceiling value of $90,000.00 and a period of performance from July 1, 2025 to June 30, 2030.

The EPC VII program requires the prime contractor to provide a variety of evidence synthesis services, including systematic reviews, scoping reviews, living reviews, rapid reviews, and qualitative evidence synthesis, across a wide range of medical specialties. The contractor must have expertise in areas such as evidence synthesis methodology, project management, statistics, stakeholder engagement, medical writing, and clinical content knowledge. The evidence synthesis products are intended to inform clinical practice guidelines, coverage decisions, research agendas, and other healthcare policies and initiatives for federal agencies, guideline developers, clinicians, patients, and other stakeholders.

Generated 6/26/25, 9:43 AM